Back to Oncology
Oncologyv1989Evidence-Based

Mirels' Criteria for Prophylactic Fixation

Predicts risk of pathologic fracture in patients with long bone metastasis to guide prophylactic fixation decisions

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
mirels score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Mirels' Criteria for Prophylactic Fixation is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within oncology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Sum of points: Site (1-3) + Size (1-3) + Nature (1-3) + Pain (1-3) = Total (4-12 points)

Clinical Pearls & Practice Notes

  • Applies only to long bone metastases (not spine, pelvis, or ribs)
  • Predicts fracture risk at 6 months post-irradiation
  • Upper limb lesions may benefit from lower threshold (≥7 points) for prophylactic fixation
  • Consider patient-specific factors: life expectancy, functional status, surgical risk
  • High-quality imaging (CT/MRI) may provide additional information beyond plain radiographs
  • Serial assessment may be needed for lesions receiving non-surgical treatment

Evidence & Literature Citations

  1. Mirels H. Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop Relat Res. 1989 Dec;(249):256-64.
  2. Van der Linden YM, Dijkstra PD, Kroon HM, Lok JJ, Noordijk EM, Leer JW, et al. Comparative analysis of risk factors for pathological fracture with femoral metastases. J Bone Joint Surg Br. 2004 May;86(4):566-73.
  3. Nazarian A, Entezari V, Villa-Camacho JC, Zurakowski D, Snyder BD. Treatment planning and fracture prediction in patients with skeletal metastasis with CT-based rigidity analysis. Clin Cancer Res. 2014 May 1;20(9):2465-73. doi: 10.1158/1078-0432.CCR-13-2966.
  4. Evans AR, Bottros J, Grant W, Chen BY, Damron TA. Mirels' rating for humerus lesions is both reproducible and valid. Clin Orthop Relat Res. 2008 Jun;466(6):1279-84. doi: 10.1007/s11999-008-0200-0.

Score Interpretation Ranges

Low Risk4 – 7 pts

0-4% fracture risk at 6 months

Intermediate Risk8 – 8 pts

15% fracture risk at 6 months

High Risk9 – 12 pts

>33% fracture risk at 6 months

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.